During human pregnancy, the uterine spiral arteries are progressively remodelled to form dilated conduits lacking maternal vasomotor control. This phenomenon ensures that a constant supply of blood is delivered to the materno-fetal interface at an optimal velocity for nutrient exchange. Conversion of a tonic maternal arteriole composed of
will be examined, with a particular focus on the role of (i) uNK cells and (ii) the enzyme matrix metalloproteinase-12 (MMP-12). Parallels with remodelling events 40 occurring in other vascular beds will also be drawn.
interactions Throughout gestation, the developing placenta competes with maternal organs for the nutrients it requires for optimal growth and function. To ensure that blood is delivered to the materno-fetal interface without interruption, and at a velocity suitable for nutrient exchange, the uterine spiral arteries are remodelled to create heavily dilated 50 conduits lacking maternal vasomotor control [1, 2] . During the first twenty weeks of pregnancy, extravillous trophoblast (EVT) egress from placental villi and invade the decidual stroma, colonizing the spiral arteries from the outside in (interstitial invasion), or migrate along the arterial lumens, colonizing the vessels from the inside out (endovascular invasion). Subsequently, the endothelium and underlying vascular 55 smooth muscle cells (VSMC) are replaced by EVT embedded in a fibrinoid-rich matrix, although re-endothelialization of these vessels occurs later in pregnancy. The vascular extracellular matrix (ECM) of the spiral arteries, which provides mechanical strength, elasticity and structural support also undergoes substantial remodelling, altering the mechanical properties of the vascular wall. 60 Successful invasion is regulated by both maternal and fetal factors: EVT must invade the uterus to an adequate depth, and in sufficient numbers to colonise the spiral arteries to the required degree. They must secrete the correct complement of proteases necessary to degrade the diverse ECM components in the vessel wall [3] , and produce 65 and respond to chemokines and cytokines that allow them to communicate with the local decidual environment. Maternal factors influencing successful colonisation include the number of VSMC layers and deposition pattern of the ECM within the spiral arteries, as a thicker vascular wall will require more effort to remodel.
Interestingly, first pregnancy results in irreversible modification of medial elastin 70 fibres which may promote vessel dilatation in future pregnancies [4] . The number of gap junctions and cell adhesion molecules within the VSMC layers will influence the ease by which EVT penetrate the vascular wall, and the level of expression of cell surface receptors for vasoactive factors will determine how VSMC respond to exogenous stimuli. 75
Recent work by our laboratory has proposed that spiral artery remodelling occurs via a coordinated series of events involving uterine natural killer (uNK) cells, macrophages and EVT [5] . Thus, to adequately understand the processes involved, we must study (i) how these different cell types interact with each other, and (ii) their 80 individual interactions with the ECM components within their local environment.
Much attention has been paid to the eventual fate of the spiral artery VSMC [6-8], with rather less research dedicated to how remodelling is initiated, and how the vascular ECM is degraded. This review will primarily address uNK cell -VSMC interactions and the evidence implicating uNK cells as mediators of vascular 85 remodelling. It will also discuss how EVT interact with the vascular ECM, and describe some of the physiological consequences of ECM remodelling.
[1] uNK cell -VSMC interactions

Decidual leukocytes accumulate around remodelling arteries 90
It was first reported in 1998 that subtle changes in spiral artery structure are observed in the secretory phase of the menstrual cycle, and in the early pregnancy decidua prior to the arrival of EVT [9] . These have since been termed trophoblast-independent or decidual-associated remodelling events [2, 5] , and include vasodilatation, swelling or loss of the endothelium, disruption of VSMC layers and vascular cell vacuolation. 95
Early pregnancy is associated with a dramatic influx of CD45 + leukocytes into the decidua, which increase in number from approximately 8% in proliferative endometrium to 23% in secretory endometrium, reaching 32% in first trimester decidua [10] . Immunohistochemical analysis has identified these cells as uNK cells and macrophages, and their pericellular and intramural accumulation directly 100 correlates with VSMC disruption and endothelial cell loss [5] . uNK cells maintain a transient contact with the vascular wall, departing before substantial loss of vascular cells has occurred, whereas macrophages remain in remodelling arteries for longer, perhaps contributing to tissue remodelling and clearance/phagocytosis of remnants of vascular cells and ECM [11] . These observations have lead us to hypothesise that 105 uNK cells secrete soluble factors that induce disruption and dedifferentiation of VSMC, resulting in vascular changes that prime the spiral arteries for colonization by EVT.
Soluble factors produced by uNK cells induce disruption of spiral artery VSMC 110
To address this hypothesis, we obtained myometrial spiral arteries from non-pregnant, pre-menopausal women undergoing hysterectomy for reasons such as fibroids, menorrhagia, ovarian cysts or familial risk of cancer. These arteries were incubated with uNK cell conditioned medium (uNK-CM) prepared by isolating uNK cells from first trimester decidua by collagenase digestion and immuno-magnetic bead 115 separation. Following 24h in culture, uNK-CM was collected, centrifuged to remove cellular debris and stored at -20°C. In parallel, EVT were isolated from first trimester placentas by trypsin digestion and Percoll gradient centrifugation; EVT-CM and medium from uNK-EVT co-cultures was collected in the same manner. 
Several uNK-derived factors may promote remodelling events
A variety of vasoactive factors may be responsible for inducing VSMC 140 disorganisation and vessel disruption. uNK cells isolated from first trimester decidua secrete angiopoietin-1, angiopoietin-2, interferon-γ and vascular endothelial growth factor-C (VEGF-C) [13, 14] , and unremodelled spiral arteries correspondingly express VEGF receptor-2 and Tie2 [14] . uNK cells also produce matrix metalloproteinase-2 (MMP-2), MMP-7 and MMP-9 [5, 11, 15] , which degrade 145 collagen IV, laminin and elastin and have been implicated as mediators of decidual vascular remodelling [5, 11] . The ability of uNK cells to promote trophoblast invasion via release of VEGF-A, placental growth factor, interleukin-8, and interferoninducible protein-10 has recently been reported [16] , and a role for uNK cell-derived VEGF-C in enhancing endovascular EVT function in vitro has also been described 150 [17] . ELISA and multiplex assays have confirmed that uNK-CM contains angiopoietin-1, angiopoietin-2, interferon-γ, VEGF-C, MMP-2 and MMP-9 [13] [14] [15] ; however, more work is required to investigate the ability of individual cytokines and growth factors to initiate vascular destabilisation.
155
Trophoblast-independent remodelling events are observed in murine pregnancy
Trophoblast-independent alterations in spiral artery architecture are also observed in the mouse, both in pseudo-pregnancy, where the uterine arteries display an increased luminal diameter and medial cross section [18] , and throughout gestation, where extensive vascular dilatation occurs despite minimal penetration of the uterus by 160 trophoblast [19] . In contrast to humans, spiral artery remodelling in the mouse is principally regulated by uNK cells. Remodelling fails to occur in mice deficient in uNK cells; however, reconstitution of the uNK cell population by bone marrow transplantation [20] , or administration of interferon-γ [21] rescues this phenotype.
These findings provide more evidence that uNK cells may contribute to remodelling 165 events in the human placental bed.
NK cells promote arterial remodelling in other vascular beds
Several studies have shown that peripheral blood NK (PBNK) cells, which are phenotypically distinct from uNK cells, mediate remodelling events in a variety of 170 vascular beds. Arteriogenesis was impaired in a mouse model of hind limb ischemia following PBNK cell depletion [22] , and atherosclerotic lesion size was reduced by 70% in LDL receptor null mice following inactivation of PBNK cell function [23] .
Furthermore, in common with the early stages of spiral artery remodelling in pregnancy, where uNK cells assume a perivascular distribution [5] , remodelling of 175 mesenteric arteries in a mouse model of hypertension was associated with an influx of PBNK cells into the vessel wall [24] . Although their mechanism of action has not been addressed in detail, these data imply that NK cells have the ability to regulate many different aspects of vascular transformation.
[2] EVT -ECM interactions EVT mediate catabolism of the vascular extracellular matrix
The ability of EVT to transform the uterine spiral arteries is highly dependent on their capacity to remodel the vascular ECM. ECM components present within the arterial 185 wall include collagen IV, laminin, proteoglycans and elastic fibres, all of which are synthesised by endothelial cells and VSMC. We have proposed that degradation of elastin fibres within the arterial wall is the rate limiting step in the remodelling process, as we believe that permanent vasodilatation cannot be established without elimination of the stretch and recoil response. Whilst breakdown of other ECM 190 components within the spiral arteries is undoubtedly important, we have chosen to focus on the mechanisms of elastin catabolism. Interestingly, EVT can be observed migrating through breaks in the internal elastin lamina in the first trimester placental bed [25] , and EVT are able to degrade elastin and phagocytose the resulting fragments in vitro [26] . 195
To identify the elastolytic proteases responsible, we performed an elastase activity assay on trophoblast cell lysates in the presence of several different broad spectrum protease inhibitors. We demonstrated that the majority of elastase activity was attributable to matrix metalloproteinases (MMP), rather than cathepsins, caspases or 200 urokinase plasminogen activator (uPA) [26] . Microarray analysis identified the most highly expressed mRNA transcripts in first trimester EVT as MMP-2 and MMP-12.
Previous reports have described MMP-2 as an important mediator of trophoblast migration and invasion [27]; however, a role for MMP-12 in EVT function has never been described. 205
EVT-derived MMP-12 is a functional elastolytic protease
MMP-12, which is also named macrophage metalloelastase, is an extracellular zinc endopeptidase. It is synthesized as a 54kDa proenzyme, which is processed to liberate a 45kDa NH 2 -terminal active form, following loss of the pro-domain [28] . Successive 10 processing releases the hemopexin domain and liberates the 22kDa mature form of MMP-12. Like other MMP, MMP-12 is secreted as inactive zymogen, but in macrophages it can be activated whilst still attached to the plasma membrane [29] .
This finding also appears to hold true in trophoblasts, as elastase activity was localised to the plasma membrane in our experiments, rather than the cytoplasm or the 215 culture supernatants [26] .
Immunohistochemistry was used to validate the microarray data and confirm MMP-12 in isolated first trimester trophoblasts. Using an antibody that was specific for the catalytic domain, it was possible to demonstrate that active MMP-12 was present on 220 the trophoblast cell surface. Furthermore, inclusion of a specific inhibitor of MMP-12 in the elastase activity assay reduced the activity of trophoblast lysates to approximately 40% of control values, indicating that MMP-12 is functionally active.
To determine whether MMP-12 is expressed in situ, first trimester placenta and decidua from 8-12 weeks gestation was also immunostained. MMP-12 expression 225 was localised to the cytotrophoblast layer and cell columns of first trimester placenta, and immuno-positive cells were also observed in the villous stroma, likely corresponding to placental macrophages (Hofbauer cells). In the decidua, stromal cells were positive for MMP-12, as was the vascular endothelium. Both interstitial and endovascular EVT, identified using antibodies to cytokeratin-7 and HLA-G 230 respectively, also expressed MMP-12. MMP-12-positive VSMC were absent from intact arteries; however, a subset of positive VSMC were observed in remodelling vessels. This observation fits neatly with the finding that MMP-12 expression can be induced in isolated spiral artery segments following perfusion with trophoblast conditioned medium [26] . 235
Our study has highlighted the important role of MMP-12 as a mediator of ECM remodelling in the placental bed, which may help to explain the basis of recent reports that both placental and decidual MMP-12 expression is altered in women with preeclampsia. A dramatic downregulation of MMP-12 mRNA was noted in chorionic 240 villus biopsies taken in the first trimester of pregnancy from women who went on to develop pre-eclampsia, compared to women who had a normal pregnancy outcome [30] . Similarly, MMP-12 expression was reduced in the decidua of women with preeclampsia at delivery [31] . Although little is known about the precise actions of MMP-12 in pregnancy, this enzyme has been shown to regulate invasion, leukocyte 245 chemotaxis, vascular remodelling in other systems, suggesting that it may play an important role in the first trimester placental bed.
MMP-12 -a key player in remodelling events?
As well as being a potent elastolytic enzyme, MMP-12 is capable of degrading a 250 diverse array of ECM components including type IV collagen, laminin, fibronectin, vitronectin and heparin sulphate proteoglycans. This makes it an ideal protease for mediating invasion through the decidual stroma and colonisation of the arterial wall.
MMP-12 can activate pro-MMP-2 and pro-MMP-3 and can process α1-anti-trypsin and latent transforming growth factor-β. Expression of MMP-12 in macrophages is 255 upregulated by interferon-γ and epidermal growth factor (EGF) [28] . As uNK cells in human decidua are a potent source of interferon-γ [13] , and trophoblasts are a source of EGF [32] , the potential for autocrine and paracrine regulation of MMP-12 in the placental bed is evident. MMP-12 activity may also indirectly promote trophoblast invasion. It has been postulated that MMP can induce epithelial to mesenchymal 260 transition by releasing bioactive ECM fragments and latent growth factors, and by cleaving E-cadherin which results in increased β-catenin signalling [33] . As MMP-12 mediates autocrine N-cadherin shedding from mouse aortic VSMC, which was associated with increased β-catenin signalling and proliferation [34] , EVT-derived MMP-12 may promote VSMC disruption and dedifferentiation by processing N-265 cadherin in the spiral arteries.
MMP-mediated catabolism of elastin liberates chemotactic peptides
Recent research has demonstrated that catabolism of elastin by MMP-7, MMP-9 or MMP-12 in vitro liberates a variety of small, bioactive, elastin-derived peptides 270 (EDP). Not only are these peptides chemotactic for neutrophils, fibroblasts, endothelial cells and monocytes, they have been shown to increase proliferation, upregulate expression of MMP-1, MMP-2 and MT1-MMP and induce elastin synthesis in different cell types [35] . A study of the factors regulating invasion of malignant glioma cells, which degrade the cerebral ECM and penetrate elastin-rich 275 blood vessels in the brain, noted that proliferation, migration and MMP-12 expression were significantly enhanced by EDP [36] . Similar observations hold true for melanoma cells: as well enhancing proliferation, migration and invasion in vitro, and inducing a 3-fold increase in tumour cell volume in vivo, EDP also promoted MMP-9 expression and collagen breakdown by tumour cells [37] . Processing of elastin by 280 macrophage-derived MMP-12 and subsequent release of EDP is believed to contribute the development of emphysema: release of chemotactic EDP following catabolism of elastin in the lung leads to recruitment of monocytes, their differentiation into macrophages, further MMP-12-mediated elastin catabolism and amplification of the pathology [38] . Taking all of this information into account we 285 hypothesize that bioactive products of elastin catabolism released from remodelling spiral arteries may promote recruitment of leukocytes to the vascular wall. In addition, we believe that release of EDP may establish a positive feedback loop which promotes EVT invasion, MMP-12 expression and activity and further elastin catabolism. 290
MMP-12 regulates leukocyte chemotaxis
Other targets of MMP-12 include members of the ELR (+) CXC family of chemokines, namely CXCL1, -2, -3, -5, and -8. MMP-12 can also cleave and inactivate the monocyte chemotactic proteins CCL-2, -7, -8, and -13, in the process 295 generating CCR antagonists. Interestingly, a recent study demonstrated a significantly greater number of polymorphonuclear leukocytes and macrophages in the lungs of MMP-12 -/mice than in their wild type counterparts, after administration of LPS [39] , confirming that the proteolytic actions of MMP-12 can limit acute inflammatory responses in vivo. A number of the chemokines listed above are expressed by cells 300 within the placental bed, thus their actions may also be regulated MMP-12 processing. CCL-7, a chemoattractant for uNK cells and macrophages is expressed in the first trimester decidua, along with CXCL1 [40] . CCL-8 is produced by uNK cells and is chemotactic for EVT [16] , CCL-2 is produced by decidual leukocytes, and decidual the actions of macrophage-derived MMP-12 limits leukocyte recruitment to the placental bed, by inactivating the chemotactic stimuli that attracted them. Similarly, the arrival of MMP-12-producing EVT in the walls of the spiral arteries may coordinate the withdrawal of perivascular leukocytes, via processing of local chemoattractants. 310
MMP-12, angiogenesis and thrombosis
MMP-12 is able to influence angiogenesis and thrombosis by inactivating angiostatin, an inhibitor of angiogenesis, tissue factor pathway inhibitor (TFPI) and urokinase plasminogen activator receptor (uPAR). Tumour blood vessel density was increased 315 in MMP-12 null mice, in parallel with a reduction in the circulating levels of angiostatin [42] , suggesting that MMP-12 activity can negatively regulate angiogenesis. Similarly, overexpression of MMP-12 in microvascular endothelial cells reduced angiogenesis in vitro by cleaving uPAR and disrupting its interactions with uPA, vitronectin and β-integrin, which are necessary for capillary morphogenesis 320 [43] . MMP-12 is also reported to cleave TFPI, which inhibits the tissue factor signalling pathway by binding to Factor Xa, generating a procoagulant microenvironment. These observations suggest that the capacity of MMP-12 to influence the progression of spiral artery remodelling extends far beyond its ability to promote ECM breakdown and EVT invasion. 325
Summary
Transformation of the decidual and myometrial spiral arteries in human pregnancy is regulated by a complex series of cell-cell and cell-ECM interactions (Figure 2 ). This 330 review has highlighted the potential contributions of a single cell type -the uNK cell, and a single protease -MMP-12. Evidence suggests that uNK cells secrete soluble factors that induce disruption of VSMC architecture, effectively priming the spiral arteries for more efficient colonisation by EVT. The actions of MMP-12 within the placental bed are much less well understood, but likely influence the outcome of 335 multiple remodelling events including ECM catabolism, trophoblast invasion, VSMC phenotype and leukocyte recruitment. Whilst we are beginning to understand the intricate nature of these events, there is still much more to learn. 
